Level Biotechnology Inc. (TPEX:3118)
Taiwan
· Delayed Price · Currency is TWD 33.25
0.00 (0.00%)
At close: Mar 10, 2026
Level Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,079 | 1,071 | 1,038 | 988 | 897 | 972 | Upgrade
|
| Market Cap Growth | 3.91% | 3.13% | 5.09% | 10.13% | -7.68% | - | Upgrade
|
| Enterprise Value | 877 | 893 | 662 | 575 | 493 | 578 | Upgrade
|
| Last Close Price | 33.25 | 33.00 | 30.31 | 27.48 | 23.62 | 23.98 | Upgrade
|
| PE Ratio | 13.63 | 13.44 | 16.02 | 15.71 | 15.35 | 14.26 | Upgrade
|
| PS Ratio | 1.46 | 1.45 | 1.42 | 1.50 | 1.51 | 1.44 | Upgrade
|
| PB Ratio | 1.86 | 1.85 | 1.86 | 1.80 | 1.65 | 1.78 | Upgrade
|
| P/TBV Ratio | 1.86 | 1.85 | 1.86 | 1.80 | 1.65 | 1.78 | Upgrade
|
| P/FCF Ratio | 40.06 | 39.75 | - | 15.80 | 15.38 | 6.62 | Upgrade
|
| P/OCF Ratio | 18.10 | 17.97 | 16.20 | 14.08 | 13.79 | 6.23 | Upgrade
|
| EV/Sales Ratio | 1.19 | 1.21 | 0.91 | 0.87 | 0.83 | 0.85 | Upgrade
|
| EV/EBITDA Ratio | 8.27 | 8.43 | 7.27 | 6.91 | 6.10 | 6.08 | Upgrade
|
| EV/EBIT Ratio | 10.49 | 10.69 | 8.79 | 8.51 | 7.59 | 7.32 | Upgrade
|
| EV/FCF Ratio | 32.54 | 33.16 | - | 9.19 | 8.45 | 3.94 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.08 | 0.13 | 0.15 | 0.15 | 0.13 | Upgrade
|
| Debt / FCF Ratio | 0.30 | 0.30 | - | 0.21 | 0.22 | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.35 | -0.43 | -0.83 | -0.83 | -0.84 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.91 | -1.91 | -2.64 | -5.46 | -5.59 | -4.83 | Upgrade
|
| Net Debt / FCF Ratio | -7.51 | -7.51 | 1.51 | -7.26 | -7.73 | -3.13 | Upgrade
|
| Asset Turnover | 0.87 | 0.87 | 0.89 | 0.81 | 0.74 | 0.87 | Upgrade
|
| Inventory Turnover | 4.48 | 4.48 | 5.29 | 5.43 | 6.01 | 7.43 | Upgrade
|
| Quick Ratio | 1.36 | 1.36 | 1.46 | 2.30 | 2.29 | 2.54 | Upgrade
|
| Current Ratio | 1.82 | 1.82 | 1.92 | 2.69 | 2.62 | 2.82 | Upgrade
|
| Return on Equity (ROE) | 13.98% | 13.98% | 11.68% | 11.52% | 10.76% | 12.69% | Upgrade
|
| Return on Assets (ROA) | 6.17% | 6.17% | 5.71% | 5.16% | 5.07% | 6.33% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.89% | 19.56% | 28.98% | 57.80% | 58.76% | 50.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.10% | 14.10% | 13.10% | 11.90% | 11.60% | 14.00% | Upgrade
|
| Earnings Yield | 7.39% | 7.44% | 6.24% | 6.37% | 6.52% | 7.02% | Upgrade
|
| FCF Yield | 2.50% | 2.51% | -15.37% | 6.33% | 6.50% | 15.10% | Upgrade
|
| Dividend Yield | 5.33% | - | 5.94% | 6.19% | 7.20% | 7.92% | Upgrade
|
| Payout Ratio | 73.29% | 73.30% | 85.12% | 87.70% | 105.46% | 76.16% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | -0.04% | 0.02% | 0.04% | -0.01% | -0.19% | Upgrade
|
| Total Shareholder Return | 5.29% | -0.04% | 5.96% | 6.22% | 7.19% | 7.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.